{"id":"azithromycin-oral-product","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-5","effect":"Nausea"},{"rate":"2-5","effect":"Abdominal pain"},{"rate":"1-3","effect":"Vomiting"},{"rate":"rare","effect":"QT prolongation"},{"rate":"rare","effect":"Hepatotoxicity"},{"rate":"1-2","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin is a macrolide antibiotic that binds to bacterial ribosomal RNA and inhibits peptide translocation, preventing the formation of the initiation complex and halting protein synthesis. This bacteriostatic action allows the immune system to clear the infection. It has a broad spectrum of activity against gram-positive and some gram-negative bacteria, as well as atypical organisms.","oneSentence":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby stopping bacterial growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:41:14.732Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial sinusitis"},{"name":"Acute otitis media"},{"name":"Pharyngitis/tonsillitis"},{"name":"Uncomplicated skin and soft tissue infections"},{"name":"Sexually transmitted infections (Chlamydia trachomatis, Neisseria gonorrhoeae)"}]},"trialDetails":[{"nctId":"NCT04185402","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-05-29","conditions":"Trachoma","enrollment":3931},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT04287049","phase":"PHASE2","title":"A Study of Standard Drugs for Mycobacterium Avium Complex","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-02-24","conditions":"Mycobacterium Avium Complex","enrollment":10},{"nctId":"NCT06289647","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma B","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2024-10","conditions":"Trachoma","enrollment":""},{"nctId":"NCT07445282","phase":"PHASE4","title":"This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever","status":"COMPLETED","sponsor":"Sheikh Zayed Medical College","startDate":"2025-05-14","conditions":"Extensively Drug-Resistant Typhoid Fever, Typhoid Fever, Salmonella Typhi Infection","enrollment":90},{"nctId":"NCT05922761","phase":"PHASE2","title":"BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-05-31","conditions":"Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases","enrollment":45},{"nctId":"NCT05796362","phase":"PHASE1","title":"A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2024-08-08","conditions":"Infectious Disease, Drug Effect, Clinical Infection","enrollment":18},{"nctId":"NCT03672630","phase":"PHASE2, PHASE3","title":"Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease","status":"COMPLETED","sponsor":"Kevin Winthrop","startDate":"2019-02-22","conditions":"Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection","enrollment":474},{"nctId":"NCT07314281","phase":"PHASE4","title":"Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever","status":"RECRUITING","sponsor":"Indus Hospital and Health Network","startDate":"2025-04-22","conditions":"Enteric Fever","enrollment":40},{"nctId":"NCT04310930","phase":"PHASE2, PHASE3","title":"Finding the Optimal Regimen for Mycobacterium Abscessus Treatment","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2020-03-02","conditions":"Pulmonary Disease Due to Mycobacteria (Diagnosis)","enrollment":300},{"nctId":"NCT03953118","phase":"PHASE4","title":"Azithromycin for Meibomian Gland Disease","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-09-01","conditions":"Dry Eye, Neuropathic Eye Pain, Ocular Microbiome","enrollment":2},{"nctId":"NCT04424511","phase":"PHASE3","title":"Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali","status":"COMPLETED","sponsor":"Tampere University","startDate":"2020-10-15","conditions":"Mortality","enrollment":149201},{"nctId":"NCT05028153","phase":"PHASE2","title":"Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms","status":"RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2022-11-14","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":320},{"nctId":"NCT04716712","phase":"PHASE4","title":"Infant Mortality Reduction by the Mass Administration of Azithromycin","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-10-04","conditions":"Child Mortality","enrollment":694400},{"nctId":"NCT04669288","phase":"PHASE3","title":"AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department","status":"TERMINATED","sponsor":"University of Arizona","startDate":"2021-09-22","conditions":"Asthma, Wheezing","enrollment":840},{"nctId":"NCT06207786","phase":"NA","title":"Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2024-09-01","conditions":"Skin Cancer, Skin Cancer Face, Malignant Cutaneous Adnexal Neoplasm","enrollment":""},{"nctId":"NCT03220074","phase":"PHASE4","title":"Linezolid for Treatment of Nontuberculous Mycobacterial Diseases","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2017-12-15","conditions":"Non-tuberculous Mycobacterial Infections","enrollment":40},{"nctId":"NCT03871491","phase":"PHASE3","title":"Azithromycin-Prevention in Labor Use Study (A-PLUS)","status":"COMPLETED","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2020-09-01","conditions":"Maternal Death, Maternal Infections Affecting Fetus or Newborn, Neonatal SEPSIS","enrollment":58747},{"nctId":"NCT04198649","phase":"PHASE3","title":"Effect of Azithromycin on Failure Proportion of Severe Periodontitis Non-surgical Treatment","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2021-11-02","conditions":"Severe Chronic Periodontitis","enrollment":6},{"nctId":"NCT04341727","phase":"PHASE3","title":"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2020-04-04","conditions":"Coronavirus Infection","enrollment":30},{"nctId":"NCT05634759","phase":"PHASE4","title":"Enhancing the A in SAFE for Trachoma","status":"COMPLETED","sponsor":"Emory University","startDate":"2022-05-04","conditions":"Trachoma","enrollment":34630},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT06149117","phase":"PHASE4","title":"Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2022-11-16","conditions":"Upper Respiratory Tract Infection, Lower Respiratory Infection, Skin Infection","enrollment":48},{"nctId":"NCT03676751","phase":"PHASE4","title":"MORDOR II Burkina Faso: Longitudinal Trial","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-10-10","conditions":"Child Growth, Diversity of Microbiome, Child Mortality","enrollment":500},{"nctId":"NCT04294069","phase":"PHASE4","title":"Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2020-09-14","conditions":"Preterm Premature Rupture of Membrane","enrollment":6},{"nctId":"NCT03683667","phase":"PHASE2, PHASE3","title":"Protein Plus: Improving Infant Growth Through Diet and Enteric Health","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2018-09-23","conditions":"Stunting, Malnutrition; Protein, Enteric Pathogens","enrollment":5283},{"nctId":"NCT04268342","phase":"NA","title":"Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII)","status":"UNKNOWN","sponsor":"The University of Queensland","startDate":"2022-04-26","conditions":"Drug Resistance, Microbial, Antimicrobial Stewardship, Gonorrhea","enrollment":1626},{"nctId":"NCT02047981","phase":"PHASE4","title":"Mortality Reduction After Oral Azithromycin: Mortality Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2014-12","conditions":"Childhood Mortality","enrollment":190238},{"nctId":"NCT04354428","phase":"PHASE2, PHASE3","title":"Treatment for COVID-19 in High-Risk Adult Outpatients","status":"TERMINATED","sponsor":"University of Washington","startDate":"2020-04-16","conditions":"COVID-19, SARS-CoV-2","enrollment":289},{"nctId":"NCT05437783","phase":"PHASE1","title":"Influence of Ethnicity and ABCB1 Gene Polymorphism on the Pharmacokinetics of Azithromycin in Healthy Bangladeshi Volunteers","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2020-01-01","conditions":"Comparative Bioavailability Study","enrollment":24},{"nctId":"NCT04322123","phase":"PHASE3","title":"Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)","status":"COMPLETED","sponsor":"Hospital do Coracao","startDate":"2020-04-01","conditions":"Coronavirus Infections","enrollment":667},{"nctId":"NCT04553406","phase":"PHASE2","title":"Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease","status":"TERMINATED","sponsor":"Spero Therapeutics","startDate":"2020-12-03","conditions":"Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease","enrollment":2},{"nctId":"NCT04179461","phase":"PHASE2","title":"Personalized Treatment Algorithms for Difficult-to-treat Asthma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-03-16","conditions":"Asthma in Children","enrollment":21},{"nctId":"NCT04673214","phase":"PHASE3","title":"Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment","status":"COMPLETED","sponsor":"Gilberto Cruz Arteaga","startDate":"2020-12-16","conditions":"Covid19","enrollment":114},{"nctId":"NCT04353180","phase":"PHASE3","title":"Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-08","conditions":"COVID19","enrollment":100000},{"nctId":"NCT03490123","phase":"PHASE4","title":"Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-04-16","conditions":"Yaws","enrollment":56000},{"nctId":"NCT04933864","phase":"PHASE1","title":"COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-04-24","conditions":"SARS-CoV-2","enrollment":60},{"nctId":"NCT03268902","phase":"PHASE2, PHASE3","title":"Early Life Interventions for Childhood Growth and Development In Tanzania","status":"COMPLETED","sponsor":"Haydom Lutheran Hospital","startDate":"2017-09-05","conditions":"Malnutrition, Stunting, Cognitive Development","enrollment":1188},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02048007","phase":"PHASE4","title":"Mortality Reduction After Oral Azithromycin: Morbidity Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2014-11","conditions":"Childhood Mortality","enrollment":72000},{"nctId":"NCT02372383","phase":"NA","title":"Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-10","conditions":"Cystic Fibrosis","enrollment":31},{"nctId":"NCT04411433","phase":"PHASE3","title":"Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19","status":"UNKNOWN","sponsor":"Ministry of Health, Turkey","startDate":"2020-05-08","conditions":"Sars-CoV2, COVID-19","enrollment":1008},{"nctId":"NCT03608774","phase":"PHASE4","title":"Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-13","conditions":"Anal Chlamydia Infection","enrollment":177},{"nctId":"NCT04542694","phase":"PHASE3","title":"Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19","status":"COMPLETED","sponsor":"Promomed, LLC","startDate":"2020-05-21","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04463420","phase":"NA","title":"Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19","status":"UNKNOWN","sponsor":"Baqiyatallah Medical Sciences University","startDate":"2020-08-15","conditions":"COVID-19","enrollment":224},{"nctId":"NCT04361422","phase":"PHASE3","title":"Isotretinoin in Treatment of COVID-19","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2020-12-01","conditions":"COVID-19","enrollment":300},{"nctId":"NCT04392128","phase":"PHASE2","title":"Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)","status":"WITHDRAWN","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2020-09-02","conditions":"COVID19, Hematologic Malignancy","enrollment":""},{"nctId":"NCT04502342","phase":"PHASE2","title":"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":30},{"nctId":"NCT04501965","phase":"PHASE2","title":"Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":231},{"nctId":"NCT04344457","phase":"PHASE1, PHASE2","title":"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19","status":"UNKNOWN","sponsor":"Perseverance Research Center, LLC","startDate":"2020-04-16","conditions":"COVID-19","enrollment":80},{"nctId":"NCT03278808","phase":"PHASE2","title":"Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis","status":"WITHDRAWN","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2018-09-17","conditions":"Malaria","enrollment":""},{"nctId":"NCT03944317","phase":"NA","title":"Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)","status":"UNKNOWN","sponsor":"Federal Medical Centre, Owo","startDate":"2019-06-01","conditions":"Malaria in Pregnancy, Pregnancy","enrollment":168},{"nctId":"NCT03578679","phase":"NA","title":"Treatment of Pediculosis (Head Lice) in Senegal","status":"COMPLETED","sponsor":"Institut de Recherche pour le Developpement","startDate":"2018-07-11","conditions":"Pediculoses","enrollment":450},{"nctId":"NCT02605122","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia","status":"TERMINATED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2016-04","conditions":"Community-acquired Bacterial Pneumonia","enrollment":97},{"nctId":"NCT01955252","phase":"PHASE3","title":"Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2013-03","conditions":"Yaws","enrollment":16000},{"nctId":"NCT01026064","phase":"PHASE1","title":"Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06-04","conditions":"Inflammation","enrollment":44},{"nctId":"NCT01671280","phase":"","title":"Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-09-20","conditions":"Pneumonia, Pelvic Inflammatory Disease","enrollment":403},{"nctId":"NCT00322972","phase":"PHASE4","title":"Trachoma Amelioration in Northern Amhara (TANA)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2006-06","conditions":"Trachoma, Chlamydia","enrollment":33000},{"nctId":"NCT02380625","phase":"PHASE1, PHASE2","title":"Multiple Treatments for Ebola Virus Disease (EVD)","status":"UNKNOWN","sponsor":"Clinical Research Management, Inc.","startDate":"2015-04","conditions":"Ebola Virus Disease","enrollment":150},{"nctId":"NCT01103713","phase":"PHASE3","title":"Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa","status":"TERMINATED","sponsor":"Pfizer","startDate":"2011-03","conditions":"Asymptomatic Parasitemia In Pregnancy","enrollment":168},{"nctId":"NCT01661985","phase":"PHASE4","title":"Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced","status":"UNKNOWN","sponsor":"Ostergotland County Council, Sweden","startDate":"2010-02","conditions":"Urethritis, Cervicitis, Genital Mycoplasma Infection","enrollment":160},{"nctId":"NCT01323582","phase":"PHASE2","title":"Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis","status":"TERMINATED","sponsor":"University of Florida","startDate":"2009-02","conditions":"Gastroparesis","enrollment":26},{"nctId":"NCT02224040","phase":"PHASE4","title":"Typhoid Fever: Combined vs. Single Antibiotic Therapy","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2013-08","conditions":"Typhoid Fever","enrollment":120},{"nctId":"NCT01136850","phase":"PHASE3","title":"Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea","status":"COMPLETED","sponsor":"University of Melbourne","startDate":"2009-11","conditions":"Malaria in Pregnancy, Sexually Transmitted Infections, Anaemia","enrollment":2793},{"nctId":"NCT00232154","phase":"PHASE2","title":"A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To","status":"COMPLETED","sponsor":"Pfizer","startDate":"2005-11","conditions":"Sinusitis","enrollment":72},{"nctId":"NCT00000966","phase":"PHASE1","title":"A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS","status":"COMPLETED","sponsor":"Pfizer","startDate":"","conditions":"Toxoplasmosis, Cerebral, HIV Infections","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zithromax","Azithrocin"],"phase":"marketed","status":"active","brandName":"Azithromycin Oral Product","genericName":"Azithromycin Oral Product","companyName":"Thomas Jefferson University","companyId":"thomas-jefferson-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby stopping bacterial growth. Used for Community-acquired pneumonia, Acute bacterial sinusitis, Acute otitis media.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}